YolTech Therapeutics

Some of the best links we picked up around the internet

CMN Weekly (21 November 2025) - Your Weekly CRISPR...

CMN Weekly

Nov. 21, 2025

Some of the best links we picked up around the internet

CMN Weekly (12 September 2025) - Your Weekly...

CMN Weekly

Sep. 12, 2025

Some of the best links we picked up around the internet

CMN Weekly (5 September 2025) - Your Weekly CRISPR...

CMN Weekly

Sep. 5, 2025

Some of the best links we picked up around the internet

CMN Weekly (29 August 2025) - Your Weekly CRISPR...

CMN Weekly

Aug. 29, 2025

Some of the best links we picked up around the internet

CMN Weekly (1 August 2025) - Your Weekly CRISPR...

CMN Weekly

Aug. 1, 2025

Some of the best links we picked up around the internet

YOLT-203 Awarded EMA Orphan Drug Designation for...

Jul. 30, 2025

YolTech Therapeutics announced earlier this week that the European Medicines Agency has granted Orphan Drug Designation to YOLT-203, its...

CMN Weekly (18 July 2025) - Your Weekly CRISPR...

CMN Weekly

Jul. 18, 2025

Some of the best links we picked up around the internet

YolTech Therapeutics

Familial Hypercholesterolemia, (NCT06458010)
Sponsors:
RenJi Hospital

IND Enabling

Phase I

Phase II

Phase III

Type 1 Primary Hyperoxaluria, PH1, (NCT06511349)
Sponsors:
RenJi Hospital

IND Enabling

Phase I

Phase II

Phase III

Transthyretin Amyloidosis, ATTR, (NCT06539208)
Sponsors:
YolTech Therapeutics Co., Ltd

IND Enabling

Phase I

Phase II

Phase III

Familial Hypercholesterolemia, FH, (NCT06461702)
Sponsors:
YolTech Therapeutics

IND Enabling

Phase I

Phase II

Phase III

Transthyretin Amyloidosis Cardiomyopathy, TTR, (NCT06082050)
Sponsors:
YolTech Therapeutics

IND Enabling

Phase I

Phase II

Phase III